MedTrace Logo

Immune Responses to COVID-19 Infection or Vaccination

NCT05379478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2025-08-07

No results posted yet for this study

Summary

The overall purpose of this observational cohort study is to characterize COVID-specific immune responses to SARS-CoV-2 exposure or COVID vaccination in a real-world setting. Participants will be asked to provide blood samples (either a normal venous blood draw, a few drops of blood obtained with a small finger-stick device, or both), as well as saliva or nasal swab sample at a series of visits. Subjects will receive results of the testing that is approved for routine clinical use (i.e., their AditxtScore), while residual samples from each visit will be stored for future testing. These efforts will support ongoing AditxtScore test development and enhance the effectiveness of its interpretation - aiding efforts to maximize benefits of clinical laboratory testing in the pandemic response.

Conditions

Interventions

DIAGNOSTIC_TEST

Laboratory assessment of antibody profiles

Antibody profiles will be determined on submitted plasma samples

Sponsors & Collaborators

  • Aditxt, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Varvel, PhD · Aditxt, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05379478 on ClinicalTrials.gov